These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1453095)

  • 1. Attacking today's tuberculosis problem: a multifaceted, coordinated effort.
    Degraw C; Fontaine B; Hebert LJ
    J La State Med Soc; 1992 Aug; 144(8):371-3. PubMed ID: 1453095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS and multidrug-resistant tuberculosis: an epidemic transforms an old disease.
    Farley TA
    J La State Med Soc; 1992 Aug; 144(8):357-61. PubMed ID: 1453093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant nosocomial TB: newest facet of the HIV epidemic.
    Abrutyn E
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):11, 15-6. PubMed ID: 1522165
    [No Abstract]   [Full Text] [Related]  

  • 4. Current concepts in the management and prevention of tuberculosis in adults.
    Fox CW; George RB
    J La State Med Soc; 1992 Aug; 144(8):363-8. PubMed ID: 1453094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985-1993. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Dupon M; Texier-Maugein J; Leroy V; Sentilhes A; Pellegrin JL; Morlat P; Ragnaud JM; Chêne G; Dabis F
    AIDS; 1995 Jun; 9(6):577-83. PubMed ID: 7662196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
    de Kantor IN; Latini O; Barrera L
    Medicina (B Aires); 1998; 58(2):202-8. PubMed ID: 9706257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program].
    García-García ML; Sifuentes-Osornio J; Jiménez-Corona ME; Ponce-de-León A; Jiménez-Corona A; Bobadilla-del Valle M; Palacios-Martínez M; Canales G; Sanginés A; Jaramillo Y; Martínez-Gamboa A; Balandrano S; Valdespino-Gómez JL; Small P
    Rev Invest Clin; 2001; 53(4):315-23. PubMed ID: 11599478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.
    Hongthiamthong P; Chuchottaworn C; Amatayakul N
    J Med Assoc Thai; 1994 Jul; 77(7):363-7. PubMed ID: 7876754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and management of HIV/TB co-infection in Asia.
    Goldfeld A; Ellner JJ
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S26-30. PubMed ID: 17606407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis].
    Katalinić-Janković V; Obrovac M
    Acta Med Croatica; 2004; 58(4):323-8. PubMed ID: 15700689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].
    Moreira CA; Hernández HL; Arias NL; Castaño MC; Ferro BE; Jaramillos E
    Biomedica; 2004 Jun; 24 Supp 1():73-9. PubMed ID: 15495574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
    Abate G
    Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand.
    Punnotok J; Shaffer N; Naiwatanakul T; Pumprueg U; Subhannachart P; Ittiravivongs A; Chuchotthaworn C; Ponglertnapagorn P; Chantharojwong N; Young NL; Limpakarnjanarat K; Mastro TD
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):537-43. PubMed ID: 10864184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.